SCHEMBL3092886

SCHEMBL3092886

CC(C)=CCCC(C)=CCc1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.50
VKORC1 Q9BQB6 1/20 0.49
PGR P06401 1/20 0.46
HTR1A P08908 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
MAPT P10636 1/20 0.46
PTGS1 P23219 1/20 0.46
PDE4A P27815 1/20 0.46
MAPK1 P28482 1/20 0.46
DRD3 P35462 1/20 0.46
SNCA P37840 1/20 0.46
PDE3A Q14432 1/20 0.46
PPARG P37231 1/20 0.46
PPARA Q07869 1/20 0.46
KMT2A Q03164 1/20 0.43
PTPN1 P18031 1/20 0.42
BACE1 P56817 1/20 0.42
MAOA P21397 1/20 0.42
OSBP P22059 1/20 0.41
ALOX15 P16050 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3092872 1.00 ACHE (0.50) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL3682565 0.85 XPO1 (0.51)
SCHEMBL24074937 0.84 VKORC1 (0.55) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL31316302 0.83 VKORC1 (0.57) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL8997133 0.81 ACHE (0.54) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL8997136 0.81 ACHE (0.54) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL5823579 0.80 ACHE (0.56) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL28432644 0.80 PTGS1 (0.52) ACHEVKORC1PGRHTR1AADORA3
SCHEMBL31464249 0.79 MTNR1A (0.46)
SCHEMBL10907648 0.78 PPARG (0.55) ACHEVKORC1PTGS1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8629268-B2 Cyclisation process of forming a multiple ring compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-01-14 US disclosed
US-20130046090-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-02-21 US disclosed
US-8227645-B2 Cyclisation process of forming a multiple ring compound NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-07-24 US disclosed
US-20100228058-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100228058-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND DHPS, GGPS1, COASY ACHE 2529/4885VKORC1 31/4885PGR 1637/4885
US-20130046090-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND COASY, AKR1C4, AKR1C2 ACHE 1794/4885VKORC1 93/4885PGR 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.